Newsletter | November 8, 2022

11.08.22 -- Patient Centricity In Oncology Therapies

Patient-Centered Drug Development For Oncology Products

While drug developers have been primarily concerned with satisfying regulatory requirements historically, discover how patient-centered drug development (PCDD) revolves around the patients and incorporates their voice in each phase of development.

Development Of Oncology Therapies: Tips From The FDA To Drive Success

In developing oncology therapeutics, seeking external advice early and often can give you key access to relevant experience, up-to-date perspectives, and unbiased assessments. Find out how utilization of cross-functional teams can deliver value across all disciplines.

Leveraging Target Product Profiles To Optimize Portfolio Potential

This article discusses the critical role of target product profiles (TPPs) in product development and tips and best practices for integrating these tools into and across programs to optimize portfolio potential.

Multidisciplinary Team Accelerates Immuno-Oncology Approval

In this in-depth case study for an immuno-oncology program, learn how a multidisciplinary development strategy assessment reduced a sponsor’s risk, controlled expenses, and optimized speed to market.

Understanding FDA Guidance For Pediatric Oncology Studies

Read about how the Research to Accelerate Cures and Equity (RACE) for Children Act aims to improve and expand treatment options for pediatric cancer patients.


Meet us at ASH

Contact us to learn more about how Premier Consulting can help move your oncology program to its next milestone.